• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Extracellular vesicle therapeutics for cardiac repair.用于心脏修复的细胞外囊泡疗法。
J Mol Cell Cardiol. 2025 Feb;199:12-32. doi: 10.1016/j.yjmcc.2024.11.005. Epub 2024 Nov 26.
2
A roadmap towards manufacturing extracellular vesicles for cardiac repair.用于心脏修复的细胞外囊泡制造路线图。
Trends Biotechnol. 2024 Oct;42(10):1305-1322. doi: 10.1016/j.tibtech.2024.03.010. Epub 2024 Apr 22.
3
Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics.细胞外囊泡用于治疗药物传递的策略。
J Neuroimmune Pharmacol. 2020 Sep;15(3):422-442. doi: 10.1007/s11481-019-09873-y. Epub 2019 Aug 27.
4
Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles.将治疗剂载入细胞外囊泡并生成细胞外囊泡模拟纳米囊泡的方法。
Methods. 2020 May 1;177:103-113. doi: 10.1016/j.ymeth.2020.01.001. Epub 2020 Jan 7.
5
Native and bioengineered extracellular vesicles for cardiovascular therapeutics.用于心血管治疗的天然和生物工程细胞外囊泡。
Nat Rev Cardiol. 2020 Nov;17(11):685-697. doi: 10.1038/s41569-020-0389-5. Epub 2020 Jun 1.
6
Stem cell-derived extracellular vesicles: role in oncogenic processes, bioengineering potential, and technical challenges.干细胞衍生的细胞外囊泡:在致癌过程中的作用、生物工程潜力和技术挑战。
Stem Cell Res Ther. 2019 Nov 26;10(1):347. doi: 10.1186/s13287-019-1468-6.
7
EV Cargo Sorting in Therapeutic Development for Cardiovascular Disease.心血管疾病治疗开发中的 EV 货物分拣。
Cells. 2021 Jun 15;10(6):1500. doi: 10.3390/cells10061500.
8
Emerging roles of extracellular vesicles in cardiac repair and rejuvenation.细胞外囊泡在心脏修复和再生中的新兴作用。
Am J Physiol Heart Circ Physiol. 2018 Oct 1;315(4):H733-H744. doi: 10.1152/ajpheart.00100.2018. Epub 2018 Jun 27.
9
CD81-guided heterologous EVs present heterogeneous interactions with breast cancer cells.CD81 导向的异源外泌体与乳腺癌细胞呈现出异质相互作用。
J Biomed Sci. 2024 Oct 15;31(1):92. doi: 10.1186/s12929-024-01084-9.
10
Before Translating Extracellular Vesicles into Personalized Diagnostics and Therapeutics: What We Could Do.在将细胞外囊泡转化为个性化诊断和治疗之前:我们能做些什么。
Mol Pharm. 2024 Jun 3;21(6):2625-2636. doi: 10.1021/acs.molpharmaceut.4c00185. Epub 2024 May 21.

引用本文的文献

1
Emerging Therapeutic Strategies for Heart Failure: A Comprehensive Review of Novel Pharmacological and Molecular Targets.心力衰竭的新兴治疗策略:新型药理学和分子靶点的综合综述
Cureus. 2025 Apr 1;17(4):e81573. doi: 10.7759/cureus.81573. eCollection 2025 Apr.

本文引用的文献

1
Spatially clustered type I interferon responses at injury borderzones.在损伤边界区存在空间聚集的 I 型干扰素反应。
Nature. 2024 Sep;633(8028):174-181. doi: 10.1038/s41586-024-07806-1. Epub 2024 Aug 28.
2
Inhalable Stem Cell Exosomes Promote Heart Repair After Myocardial Infarction.可吸入干细胞外泌体促进心肌梗死后的心脏修复。
Circulation. 2024 Aug 27;150(9):710-723. doi: 10.1161/CIRCULATIONAHA.123.065005. Epub 2024 Aug 26.
3
Understanding molecular characteristics of extracellular vesicles derived from different types of mesenchymal stem cells for therapeutic translation.了解源自不同类型间充质干细胞的细胞外囊泡的分子特征以用于治疗转化。
Extracell Vesicle. 2024 Jun;3. doi: 10.1016/j.vesic.2024.100034. Epub 2024 Mar 2.
4
Sucrose-based cryoprotective storage of extracellular vesicles.基于蔗糖的细胞外囊泡低温保护储存
Extracell Vesicle. 2022 Dec;1. doi: 10.1016/j.vesic.2022.100016. Epub 2022 Nov 21.
5
Expanding the horizon of EV-RNAs: LncRNAs in EVs as biomarkers for disease pathways.拓展细胞外囊泡RNA的视野:细胞外囊泡中的长链非编码RNA作为疾病通路的生物标志物
Extracell Vesicle. 2023 Dec;2. doi: 10.1016/j.vesic.2023.100025. Epub 2023 May 20.
6
Lung-to-Heart Nano-in-Micro Peptide Promotes Cardiac Recovery in a Pig Model of Chronic Heart Failure.肺心纳微肽促进慢性心力衰竭猪模型的心脏恢复。
J Am Coll Cardiol. 2024 Jan 2;83(1):47-59. doi: 10.1016/j.jacc.2023.10.029.
7
Application of Hydrogels in Cardiac Regeneration.水凝胶在心脏再生中的应用。
Cardiol Ther. 2023 Dec;12(4):637-674. doi: 10.1007/s40119-023-00339-0. Epub 2023 Nov 18.
8
Hypoxia enhances anti-fibrotic properties of extracellular vesicles derived from hiPSCs via the miR302b-3p/TGFβ/SMAD2 axis.低氧通过 miR302b-3p/TGFβ/SMAD2 轴增强 hiPSC 来源的细胞外囊泡的抗纤维化特性。
BMC Med. 2023 Oct 31;21(1):412. doi: 10.1186/s12916-023-03117-w.
9
Adaptive design of mRNA-loaded extracellular vesicles for targeted immunotherapy of cancer.载 mRNA 的细胞外囊泡的适应性设计用于癌症的靶向免疫治疗。
Nat Commun. 2023 Oct 19;14(1):6610. doi: 10.1038/s41467-023-42365-5.
10
Engineered small extracellular vesicle-mediated NOX4 siRNA delivery for targeted therapy of cardiac hypertrophy.工程化细胞外囊泡介导的 NOX4 siRNA 递送来靶向治疗心肌肥厚。
J Extracell Vesicles. 2023 Oct;12(10):e12371. doi: 10.1002/jev2.12371.

用于心脏修复的细胞外囊泡疗法。

Extracellular vesicle therapeutics for cardiac repair.

作者信息

Hu Yilan, Zhang Weihang, Ali Shah Rukh, Takeda Koji, Vahl Torsten Peter, Zhu Donghui, Hong Yi, Cheng Ke

机构信息

Department of Biomedical Engineering, Columbia University, New York, NY 10032, USA.

Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA.

出版信息

J Mol Cell Cardiol. 2025 Feb;199:12-32. doi: 10.1016/j.yjmcc.2024.11.005. Epub 2024 Nov 26.

DOI:10.1016/j.yjmcc.2024.11.005
PMID:39603560
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11788051/
Abstract

Extracellular vesicles (EVs) are cell-secreted heterogeneous vesicles that play crucial roles in intercellular communication and disease pathogenesis. Due to their non-tumorigenicity, low immunogenicity, and therapeutic potential, EVs are increasingly used in cardiac repair as cell-free therapy. There exist multiple steps for the design of EV therapies, and each step offers many choices to tune EV properties. Factors such as EV source, cargo, loading methods, routes of administration, surface modification, and biomaterials are comprehensively considered to achieve specific goals. PubMed and Google Scholar were searched in this review, 89 articles related to EV-based cardiac therapy over the past five years (2019 Jan - 2023 Dec) were included, and their key steps in designing EV therapies were counted and analyzed. We aim to provide a comprehensive overview that can serve as a reference guide for researchers to design EV-based cardiac therapies.

摘要

细胞外囊泡(EVs)是细胞分泌的异质性囊泡,在细胞间通讯和疾病发病机制中发挥着关键作用。由于其无致瘤性、低免疫原性和治疗潜力,EVs作为无细胞疗法越来越多地用于心脏修复。EV疗法的设计存在多个步骤,每个步骤都提供了许多调节EV特性的选择。为实现特定目标,需综合考虑EV来源、货物、加载方法、给药途径、表面修饰和生物材料等因素。本综述检索了PubMed和谷歌学术,纳入了过去五年(2019年1月至2023年12月)89篇与基于EV的心脏治疗相关的文章,并对其设计EV疗法的关键步骤进行了统计和分析。我们旨在提供一个全面的概述,可为研究人员设计基于EV的心脏疗法提供参考指南。